CWWM
NRIX icon

Clear Wave Wealth Management’s Nurix Therapeutics NRIX Stock Holding History

Clear Wave Wealth Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
+10,792
New +$184K 0.05% 157

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Clear Wave Wealth Management's NRIX Position: Q2 2026 in Review

Clear Wave Wealth Management opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 10,792 shares worth $262K. The stake represents 0.05% of the portfolio and ranks #157 among its holdings.

210 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Clear Wave Wealth Management held 10,792 shares of Nurix Therapeutics worth $262K as of Q2 2026.
  • Nurix Therapeutics was a new Clear Wave Wealth Management position in Q2 2026.
  • Nurix Therapeutics made up 0.05% of Clear Wave Wealth Management's portfolio in Q2 2026, its #157 holding.
  • 210 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Clear Wave Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.